Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with SNY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|5.01%||Market Vectors Pharmaceutical ETF (PPH)||+5.02 (7.31%)|
|3.48%||BLDRS Europe 100 ADR Index Fund (ADRU)||-0.11 (-0.47%)|
|3.21%||WBI Large Cap Tactical Yield Shares (WBIG)||-0.57 (-2.36%)|
|3.17%||WBI Large Cap Tactical Value Shares (WBIF)||-0.18 (-0.73%)|
|2.81%||BLDRS Developed Markets 100 ADR Index Fund (ADRD)||+0.63 (2.71%)|
Company Description (as filed with the SEC)
Sanofi is a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. In 2014, our net sales were €33,770 million. We are the fourth largest pharmaceutical group in the world and the second largest in Europe in terms of sales (IMS data). Sanofi is the parent company of a consolidated group of companies. A list of our principal subsidiaries can be found in Note F to our consolidated financial statements included at Item 18 of this annual report. The Group is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. These activities are operating segments within the meaning of the IFRS 8 accounting standard (see Note D.35. to the consolidated financial statements). We invest in the following activities (see "B. Business Overview -- B.1. ... More ...
Where does SNY fit in the risk graph?
|Annual EPS Est:||$2.98|
|Quarterly EPS Est:||0.91|